This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Cancer registries | |
|---|---|
| Name | Cancer registries |
| Type | Public health surveillance |
| Area served | Global |
| Focus | Epidemiology, oncology, surveillance |
Cancer registries are organized systems for collecting, storing, analyzing, and reporting information about individuals diagnosed with neoplastic diseases. They support clinical care, epidemiological research, health policy, and planning by linking case records across hospitals, laboratories, and administrative sources. Major health agencies, academic centers, and international bodies coordinate registry standards and use registry data for cancer control programs and outcome assessment.
Cancer registries operate at local, regional, national, and international levels including networks such as the International Agency for Research on Cancer, national programs like the Surveillance, Epidemiology, and End Results Program, and collaborative groups such as the European Network of Cancer Registries. Registries integrate inputs from clinical centers including Johns Hopkins Hospital, Mayo Clinic, and Memorial Sloan Kettering Cancer Center, and link to pathology services like Mayo Clinic Laboratories and national laboratories. Data elements commonly captured include patient identifiers, tumor site and morphology, stage, treatment episodes from centers such as Dana-Farber Cancer Institute and MD Anderson Cancer Center, and outcomes used by agencies like the Centers for Disease Control and Prevention and World Health Organization.
Early systematic reporting began in city-level systems influenced by statistical offices such as the Office for National Statistics and inspired by registries in cities like Bristol and Stockholm. Landmark developments include population-based efforts in countries represented by institutions such as the National Cancer Institute and the National Health Service that standardized incidence and survival metrics. International milestones included classification systems developed by bodies like the International Classification of Diseases and tumor nomenclature advanced by organizations such as the College of American Pathologists and the Union for International Cancer Control.
Registries fall into categories including population-based registries exemplified by the Norwegian Cancer Registry and the Australian Institute of Health and Welfare cancer collections; hospital-based registries at institutions like Cleveland Clinic and Toronto General Hospital; and specialized registries for rare diseases associated with centers such as Great Ormond Street Hospital and research consortia like the European Organisation for Research and Treatment of Cancer. Registries may be linked to administrative datasets from agencies like Medicare and national cohorts initiated by universities such as Harvard University and University of Oxford.
Data capture integrates notifications from clinical units including Royal Marsden Hospital, pathology labs such as Karolinska Institutet pathology services, and imaging centers like Mayo Clinic Imaging. Case ascertainment relies on coding systems developed by the World Health Organization, pathology protocols from the College of American Pathologists, and staging frameworks such as the American Joint Committee on Cancer TNM system. Quality control mechanisms include record linkage techniques used by statistical agencies like Statistics Canada, audit cycles practiced by the National Institutes of Health, and data validation methods employed by registries within networks such as the European Network of Cancer Registries.
Registry outputs inform cancer control strategies used by ministries such as Ministry of Health (United Kingdom), treatment guidelines by organizations like the National Comprehensive Cancer Network, and outcome research at centers including Stanford University Medical Center. Incidence and survival statistics guide screening initiatives championed by groups such as U.S. Preventive Services Task Force and vaccination programs supported by agencies like the Gavi, the Vaccine Alliance. Registries underpin clinical trials coordinated by bodies such as the European Medicines Agency and the Food and Drug Administration, and support health services research at institutions like University College London.
Governance frameworks reference laws and regulators including statutes like the Health Insurance Portability and Accountability Act and oversight by bodies such as the National Health Service data governance units. Ethical considerations involve informed consent debates addressed by academic centers like Yale School of Medicine and research ethics committees such as those at Johns Hopkins Bloomberg School of Public Health. Privacy-preserving techniques draw on cryptographic research from universities including Massachusetts Institute of Technology and policy guidance from organizations like the European Commission.
Contemporary challenges include under-ascertainment in low-resource settings represented by regions served by agencies such as the World Bank and the need for interoperability with electronic health records from providers like Epic Systems and Cerner Corporation. Future directions emphasize genomic and molecular data linkage pioneered at institutes like the Broad Institute and population-scale initiatives modeled by projects such as the UK Biobank and the All of Us Research Program. Advances in artificial intelligence from research labs at Google DeepMind and OpenAI and standards work by consortia such as the Global Alliance for Genomics and Health will shape registry capabilities and international collaboration.
Category:Cancer epidemiology